Faster and more pronounced inflammatory responses are observed in absence of CD200 in model of experimental autoimmune encephalomyelitis and an increased susceptibility to collagen-induced arthritis (17), whereas treatment with recombinant CD200 reduces disease severity in both models (18, 19). This evidence concerns the gene CD200 and experimental autoimmune encephalomyelitis.